Vikas Lifecare · NSE: VIKASLIFE · BSE: 542655

Q4 FY23 results · Jan–Mar 2023

Vikas Lifecare reported revenue from operations of ₹118.10 crore (up 15.1% from Q4 FY22) and net loss of ₹26.82 crore for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.

Consolidated · ₹ crore
Item	Q4 FY23	Q4 FY22	YoY	Q3 FY23	QoQ
Revenue from operations	118.10	102.59	+15.1%	133.94	−11.8%
Other income	(31.83)	30.79	Turned loss	0.63	Turned loss
Total income	86.26	133.38	−35.3%	134.58	−35.9%
Profit before share of associates & JVs and tax	(32.40)	31.67	Turned loss	3.48	Turned loss
Share of profit/(loss) of associates & JVs	0.04	0.09		0.00
Net profit for the period	(26.82)	23.23	Turned loss	6.19	Turned loss
Attributable to shareholders of the company	(26.88)	22.98	Turned loss	5.89	Turned loss
EPS, basic (₹)	(0.19)	0.25	not comparable	0.05	Turned loss
Net margin (%)	-22.7	22.6		4.6

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q4 FY23	Q4 FY22	YoY	Q3 FY23	QoQ
Revenue from operations	116.45	96.64	+20.5%	131.07	−11.2%
Other income	(32.30)	30.72	Turned loss	0.74	Turned loss
Total income	84.15	127.35	−33.9%	131.81	−36.2%
Profit before tax	(34.05)	30.35	Turned loss	5.32	Turned loss
Net profit for the period	(25.97)	22.15	Turned loss	8.02	Turned loss
EPS, basic (₹)	(0.18)	0.24	not comparable	0.06	Turned loss
Net margin (%)	-22.3	22.9		6.1

Consolidated

Filed with BSE: 23 May 2023, 18:20 IST
Board meeting: 23 May 2023
Period: 01 Jan 2023 to 31 Mar 2023
Review status: Audited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 23 May 2023, 18:20 IST
Board meeting: 23 May 2023
Period: 01 Jan 2023 to 31 Mar 2023
Review status: Audited
Source: XBRL filing on BSE